4//SEC Filing
ALNYLAM PHARMACEUTICALS, INC. 4
Accession 0001553878-16-000038
$ALNYCIK 0001178670operating
Filed
Feb 23, 7:00 PM ET
Accepted
Feb 24, 6:21 PM ET
Size
6.0 KB
Accession
0001553878-16-000038
Insider Transaction Report
Form 4
Gros David-Alexandre C
SVP, Chief Business Officer
Transactions
- Purchase
Common Stock
2016-02-22$62.74/sh+100$6,274→ 100 total - Purchase
Common Stock
2016-02-22$62.75/sh+900$56,475→ 1,000 total
Footnotes (1)
- [F1]The open market purchase of Common Stock reported on this Form 4 was made by the reporting person on February 22, 2016.
Documents
Issuer
ALNYLAM PHARMACEUTICALS, INC.
CIK 0001178670
Entity typeoperating
Related Parties
1- filerCIK 0001178670
Filing Metadata
- Form type
- 4
- Filed
- Feb 23, 7:00 PM ET
- Accepted
- Feb 24, 6:21 PM ET
- Size
- 6.0 KB